Transgene Announces Upcoming Investor Meetings
By alcyon|2019-06-03T19:41:04+02:00December 5th, 2018|Press release|Comments Off on Transgene Announces Upcoming Investor Meetings
About the Author: alcyon
Related Posts
- First Head & Neck Cancer Patient Treated in France in a Phase I trial with TG4050 (myvac® Platform), Transgene’s Innovative Individualized Immunotherapy
First Head & Neck Cancer Patient Treated in France in a Phase I trial with TG4050 (myvac® Platform), Transgene’s Innovative Individualized Immunotherapy